Correlation Between Adaptimmune Therapeutics and Atea Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Adaptimmune Therapeutics and Atea Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptimmune Therapeutics and Atea Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adaptimmune Therapeutics Plc and Atea Pharmaceuticals, you can compare the effects of market volatilities on Adaptimmune Therapeutics and Atea Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptimmune Therapeutics with a short position of Atea Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptimmune Therapeutics and Atea Pharmaceuticals.
Diversification Opportunities for Adaptimmune Therapeutics and Atea Pharmaceuticals
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Adaptimmune and Atea is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Adaptimmune Therapeutics Plc and Atea Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atea Pharmaceuticals and Adaptimmune Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptimmune Therapeutics Plc are associated (or correlated) with Atea Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atea Pharmaceuticals has no effect on the direction of Adaptimmune Therapeutics i.e., Adaptimmune Therapeutics and Atea Pharmaceuticals go up and down completely randomly.
Pair Corralation between Adaptimmune Therapeutics and Atea Pharmaceuticals
Given the investment horizon of 90 days Adaptimmune Therapeutics Plc is expected to under-perform the Atea Pharmaceuticals. In addition to that, Adaptimmune Therapeutics is 2.7 times more volatile than Atea Pharmaceuticals. It trades about 0.0 of its total potential returns per unit of risk. Atea Pharmaceuticals is currently generating about 0.0 per unit of volatility. If you would invest 342.00 in Atea Pharmaceuticals on August 28, 2024 and sell it today you would lose (2.00) from holding Atea Pharmaceuticals or give up 0.58% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Adaptimmune Therapeutics Plc vs. Atea Pharmaceuticals
Performance |
| Timeline |
| Adaptimmune Therapeutics |
| Atea Pharmaceuticals |
Adaptimmune Therapeutics and Atea Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adaptimmune Therapeutics and Atea Pharmaceuticals
The main advantage of trading using opposite Adaptimmune Therapeutics and Atea Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptimmune Therapeutics position performs unexpectedly, Atea Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will offset losses from the drop in Atea Pharmaceuticals' long position.The idea behind Adaptimmune Therapeutics Plc and Atea Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Atea Pharmaceuticals vs. Immix Biopharma | Atea Pharmaceuticals vs. Cns Pharmaceuticals | Atea Pharmaceuticals vs. Hepion Pharmaceuticals | Atea Pharmaceuticals vs. Enveric Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |